{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:25:54Z","timestamp":1790839554609,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1020,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["37772"],"award-info":[{"award-number":["37772"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-F3-2009-241745"],"award-info":[{"award-number":["HEALTH-F3-2009-241745"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.immuni.2010.09.015","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T04:38:05Z","timestamp":1288327085000},"page":"567-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Future Vaccination Strategies against Tuberculosis: Thinking outside the Box"],"prefix":"10.1016","volume":"33","author":[{"given":"Stefan H.E.","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2010.09.015_bib1","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2010.09.015_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2010.09.015_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.trstmh.2008.03.014","article-title":"New vaccines against tuberculosis: Lessons learned from BCG immunisation in Brazil","volume":"102","author":"Antas","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.immuni.2010.09.015_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2010.09.015_bib5","first-page":"1331","article-title":"Bacille Calmette-Gu\u00e9rin vaccine-related disease in HIV-infected children: A systematic review","volume":"13","author":"Azzopardi","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"Bangari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/iai.64.5.1794-1799.1996","article-title":"Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages","volume":"64","author":"Bange","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2010.09.015_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T\u00a0cells in the control of host-microorganism interactions (\u2217)","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"16","author":"Black","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.immunol.22.012703.104608","article-title":"CD1: Antigen presentation and T\u00a0cell function","volume":"22","author":"Brigl","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib12","first-page":"201","article-title":"Sur la vaccination pr\u00e9ventive des enfants nouveau-n\u00e9s contre la tuberculose par le BCG","volume":"41","author":"Calmette","year":"1927","journal-title":"Annales de l'Institut Pasteur"},{"key":"10.1016\/j.immuni.2010.09.015_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","article-title":"CTLA-4-mediated inhibition in regulation of T\u00a0cell responses: Mechanisms and manipulation in tumor immunotherapy","volume":"19","author":"Chambers","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T\u00a0cells suppress Mycobacterium tuberculosis immunity in patients with active disease","volume":"123","author":"Chen","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib16","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/593175","article-title":"Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci","volume":"198","author":"Cosma","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","article-title":"The role of the granuloma in expansion and dissemination of early tuberculous infection","volume":"136","author":"Davis","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2010.09.015_bib18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/eji.201040299","article-title":"Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis","volume":"40","author":"Day","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/eji.200838543","article-title":"Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways","volume":"39","author":"Dennehy","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.coi.2006.05.019","article-title":"Autophagy as an immune defense mechanism","volume":"18","author":"Deretic","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib21","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: Efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ni.1904","article-title":"Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis","volume":"11","author":"Divangahi","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-3083.1999.00492.x","article-title":"In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement","volume":"49","author":"Dlugovitzky","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.coi.2009.07.004","article-title":"Fine-tuning of T\u00a0cell responses during infection","volume":"21","author":"Dorhoi","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20090067","article-title":"The adaptor molecule CARD9 is essential for tuberculosis control","volume":"207","author":"Dorhoi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"Dye","year":"2008","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.immuni.2010.09.015_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1174182","article-title":"IL-21 is required to control chronic viral infection","volume":"324","author":"Elsaesser","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib28","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: Implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2010.09.015_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T\u00a0cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: Implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2010.09.015_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1172815","article-title":"IL-21R on T\u00a0cells is critical for sustained functionality and control of chronic viral infection","volume":"324","author":"Fr\u00f6hlich","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib32","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2010.09.015_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20021229","article-title":"Mycobacteria target DC-SIGN to suppress dendritic cell function","volume":"197","author":"Geijtenbeek","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib35","doi-asserted-by":"crossref","first-page":"e6950","DOI":"10.1371\/journal.pone.0006950","article-title":"A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A\u22170201 transgenic mice","volume":"4","author":"Gram","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2010.09.015_bib36","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2010.09.015_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm0396-334","article-title":"Auxotrophic vaccines for tuberculosis","volume":"2","author":"Guleria","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","article-title":"Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages","volume":"119","author":"Gutierrez","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2010.09.015_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T\u00a0cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"Guyot-Revol","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrmicro2321","article-title":"Regulation of antigen presentation by Mycobacterium tuberculosis: A role for Toll-like receptors","volume":"8","author":"Harding","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib41","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(10)60409-6","article-title":"The HIV-associated tuberculosis epidemic\u2014When will we act?","volume":"375","author":"Harries","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2010.09.015_bib42","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/j.vaccine.2009.05.021","article-title":"The potential impact of helminth infection on trials of novel tuberculosis vaccines","volume":"27","author":"Hatherill","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib43","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2007.06.045","article-title":"BCG and HIV reconsidered: Moving the research agenda forward","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: Progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.immuni.2010.09.015_bib46","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","article-title":"Neglected tropical diseases in sub-saharan Africa: Review of their prevalence, distribution, and disease burden","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib47","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nm.1989","article-title":"Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T\u00a0cells","volume":"15","author":"Hutnick","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib48","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1084\/jem.20091750","article-title":"Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle","volume":"206","author":"Ishikawa","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1:PD-ligand 1\/PD-ligand 2 pathway inhibits T\u00a0cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib50","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T\u00a0cell frequency and cytokine expression profile do not correlate with protection against tuberculosis, following BCG vaccination of newborns","author":"Kagina","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in\u00a0vitro","volume":"67","author":"Kana","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future strategies for vaccination against tuberculosis","volume":"6","author":"Kaufmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2006.04.003","article-title":"Tuberculosis: Back on the immunologists' agenda","volume":"24","author":"Kaufmann","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2010.09.015_bib54","series-title":"The New Plagues: Pandemics and Poverty in a Globalized World","author":"Kaufmann","year":"2009"},{"key":"10.1016\/j.immuni.2010.09.015_bib55","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2010.09.015_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T\u00a0cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib58","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.178.5.2661","article-title":"Cutting Edge: Regulatory T\u00a0cells prevent efficient clearance of Mycobacterium tuberculosis","volume":"178","author":"Kursar","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2008.01.002","article-title":"Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain","volume":"3","author":"Lee","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2010.09.015_bib60","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.micinf.2006.03.018","article-title":"Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis","volume":"8","author":"Leyten","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.immuni.2010.09.015_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/BC.2008.057","article-title":"Not to wake a sleeping giant: New insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection","volume":"389","author":"Lin","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.immuni.2010.09.015_bib62","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.01999-06","article-title":"Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination","volume":"75","author":"Lin","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2010.09.015_bib63","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/14760584.6.5.741","article-title":"IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems","volume":"6","author":"Lingnau","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.immuni.2010.09.015_bib64","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tube.2006.01.016","article-title":"Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis","volume":"86","author":"Locht","year":"2006","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.immuni.2010.09.015_bib65","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T\u00a0cells rather than CD4 T\u00a0cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib66","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010-50: Cure, care, and social development","volume":"375","author":"L\u00f6nnroth","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2010.09.015_bib67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Gu\u00e9rin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib68","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib69","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.it.2006.03.007","article-title":"T-cell homing specificity and plasticity: New concepts and future challenges","volume":"27","author":"Mora","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","article-title":"Fc-receptors as regulators of immunity","volume":"96","author":"Nimmerjahn","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O'Brien","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib73","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T\u00a0cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib74","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2009.10.005","article-title":"The quest for biomarkers in tuberculosis","volume":"15","author":"Parida","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.immuni.2010.09.015_bib75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2010.09.015_bib76","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2010.09.015_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib78","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.micinf.2009.07.005","article-title":"Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis","volume":"11","author":"Rouanet","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.immuni.2010.09.015_bib79","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in\u00a0vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrmicro1538","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib81","series-title":"The Lung: Scientific Foundations","first-page":"371","article-title":"Use of bronchoalvaeolar lavage and airway brushing to investigate the human lung","author":"Russi","year":"1997"},{"key":"10.1016\/j.immuni.2010.09.015_bib82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T\u00a0cell subsets: Function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib83","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","article-title":"A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis","volume":"8","author":"Sambandamurthy","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib84","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib85","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals","volume":"179","author":"Sander","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib86","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2010.09.015_bib87","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nrmicro1046","article-title":"Iron and microbial infection","volume":"2","author":"Schaible","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib88","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib89","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection","volume":"4","author":"Schuck","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2010.09.015_bib90","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.2741\/3195","article-title":"Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk","volume":"13","author":"Scotet","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.immuni.2010.09.015_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00408-005-2558-2","article-title":"Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis","volume":"184","author":"Shitrit","year":"2006","journal-title":"Lung"},{"key":"10.1016\/j.immuni.2010.09.015_bib92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/QCO.0b013e328334c0e1","article-title":"Prospects for new human papillomavirus vaccines","volume":"23","author":"Stanley","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib93","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.276.5319.1684","article-title":"Differential effects of cytolytic T\u00a0cell subsets on intracellular infection","volume":"276","author":"Stenger","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T\u00a0cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib95","unstructured":"StopTB Partnership Working Group on New TB Vaccines. (2009). StopTB Tuberculosis Vaccine Pipeline 2009. http:\/\/www.stoptb.org\/wg\/new_vaccines\/assets\/documents\/TB%20Vaccine%20Pipeline%202009.pdf."},{"key":"10.1016\/j.immuni.2010.09.015_bib96","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib97","unstructured":"Sun, R., Hone, D. M., and Sadoff, J. C. February 2010.Recombinant BCG strains with enhanced ability to escape the endosome. U.S. patent 7,666,656."},{"key":"10.1016\/j.immuni.2010.09.015_bib98","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.4049\/jimmunol.1000399","article-title":"Polyfunctional CD4(+) and CD8(+) T\u00a0cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment","volume":"184","author":"Sutherland","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.20021468","article-title":"DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells","volume":"197","author":"Tailleux","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib100","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.2741\/A286","article-title":"Host response to Mycobacterium tuberculosis","volume":"3","author":"Toossi","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.immuni.2010.09.015_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature07781","article-title":"Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation","volume":"458","author":"Torchinsky","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2010.09.015_bib102","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.immuni.2010.09.015_bib103","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.1906","article-title":"New insights into the function of granulomas in human tuberculosis","volume":"208","author":"Ulrichs","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.immuni.2010.09.015_bib104","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1073\/pnas.96.25.14459","article-title":"Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages","volume":"96","author":"Underhill","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2010.09.015_bib105","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2010.09.015_bib106","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T\u00a0cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib107","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.1179663","article-title":"Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium","volume":"327","author":"Volkman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2010.09.015_bib108","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: Tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.immuni.2010.09.015_bib109","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20030205","article-title":"Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program","volume":"198","author":"Voskuil","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2010.09.015_bib110","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva Consensus: Recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2010.09.015_bib111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","article-title":"Nonreplicating persistence of mycobacterium tuberculosis","volume":"55","author":"Wayne","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2010.09.015_bib112","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","article-title":"The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Gu\u00e9rin vaccination in southern England and northern Malawi","volume":"146","author":"Weir","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib113","first-page":"193","article-title":"Revised BCG vaccination guidelines for infants at risk for HIV infection","volume":"82","year":"2007","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.immuni.2010.09.015_bib114","series-title":"Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO Report 2009","year":"2009"},{"key":"10.1016\/j.immuni.2010.09.015_bib115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","article-title":"Effector and memory CTL differentiation","volume":"25","author":"Williams","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2010.09.015_bib116","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/20.4.982","article-title":"Geographic latitude and the efficacy of bacillus Calmette-Gu\u00e9rin vaccine","volume":"20","author":"Wilson","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.immuni.2010.09.015_bib117","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10495-005-2940-6","article-title":"No life without death\u2014Apoptosis as prerequisite for T\u00a0cell activation","volume":"10","author":"Winau","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.immuni.2010.09.015_bib118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T\u00a0cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2010.09.015_bib119","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.1175194","article-title":"A vital role for interleukin-21 in the control of a chronic viral infection","volume":"324","author":"Yi","year":"2009","journal-title":"Science"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761310003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761310003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:58:20Z","timestamp":1761033500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761310003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1074761310003584"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2010.09.015","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future Vaccination Strategies against Tuberculosis: Thinking outside the Box","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2010.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}